MedPath

ASTRAZENECA HONG KONG LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

90

PPB:90

Drug Approvals

KANUMA CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/10ML

Approval Date
Jun 20, 2025
PPB

CALQUENCE TABLETS 100MG

Approval Date
Jun 17, 2025
PPB

VOYDEYA TABLETS 100MG + 100MG

Approval Date
Dec 16, 2024
PPB

TRUQAP TABLETS 200MG

Approval Date
Dec 16, 2024
PPB

TRUQAP TABLETS 160MG

Approval Date
Dec 16, 2024
PPB

VOYDEYA TABLETS 50MG + 100MG

Approval Date
Dec 16, 2024
PPB

FLUMIST TRIVALENT INFLUENZA INTRANASAL VACCINE

Approval Date
May 22, 2024
PPB

IMJUDO CONCENTRATE FOR SOLUTION FOR INFUSION 25MG/1.25ML

Approval Date
Apr 29, 2024
PPB

IMJUDO CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/15ML

Approval Date
Apr 29, 2024
PPB

ANDEXXA POWDER FOR SOLUTION FOR INFUSION 200MG

Approval Date
Feb 23, 2024
PPB
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.